Northern Trust’s Tenax Therapeutics TENX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
199,134
+187,085
+1,553% +$2.39M ﹤0.01% 2922
2026
Q1
$193K Buy
+12,049
New +$163K ﹤0.01% 3960
2023
Q1
– Sell
-22
Closed -$3.86K – 4626
2022
Q4
$3.86K Hold
22
– – ﹤0.01% 4634
2022
Q3
$6K Hold
22
– – ﹤0.01% 4671
2022
Q2
$10K Hold
22
– – ﹤0.01% 4696
2022
Q1
$28K Hold
22
– – ﹤0.01% 4635
2021
Q4
$36K Hold
22
– – ﹤0.01% 4641
2021
Q3
$61K Hold
22
– – ﹤0.01% 4499
2021
Q2
$72K Buy
22
+11
+100% +$34.9K ﹤0.01% 4425
2021
Q1
$32K Hold
11
– – ﹤0.01% 4415
2020
Q4
$32K Hold
11
– – ﹤0.01% 4279
2020
Q3
$26K Buy
11
+4
+57% +$8.54K ﹤0.01% 4181
2020
Q2
$11K Buy
+7
New +$10.3K ﹤0.01% 4210
2018
Q1
– Sell
-2
Closed -$25K – 4279
2017
Q4
$25K Hold
2
– – ﹤0.01% 4138
2017
Q3
$18K Hold
2
– – ﹤0.01% 4165
2017
Q2
$38K Hold
2
– – ﹤0.01% 4116
2017
Q1
$29K Buy
2
+1
+100% +$36.3K ﹤0.01% 4121
2016
Q4
$61K Hold
1
– – ﹤0.01% 3983
2016
Q3
$69K Hold
1
– – ﹤0.01% 3956
2016
Q2
$78K Hold
1
– – ﹤0.01% 3945
2016
Q1
$61K Hold
1
– – ﹤0.01% 3991
2015
Q4
$92K Hold
1
– – ﹤0.01% 3954
2015
Q3
$87K Hold
1
– – ﹤0.01% 3970
2015
Q2
$91K Hold
1
– – ﹤0.01% 3970
2015
Q1
$99K Hold
1
– – ﹤0.01% 4040
2014
Q4
$117K Hold
1
– – ﹤0.01% 3951
2014
Q3
$140K Hold
1
– – ﹤0.01% 3944
2014
Q2
$146K Buy
+1
New +$154K ﹤0.01% 3926
2014
Q1
– Hold
0
– – – 4025

Other funds holding TENX

Northern Trust's TENX Position: Q2 2026 in Review

Northern Trust increased its Tenax Therapeutics (TENX) stake by 1,553% in Q2 2026, buying an estimated $2.39M and bringing the position to 199,134 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2922.

Northern Trust first reported a position in TENX in Q2 2014 and has held it in 28 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Northern Trust held 199,134 shares of Tenax Therapeutics worth $2.9M as of Q2 2026.
  • Northern Trust bought 187,085 Tenax Therapeutics shares in Q2 2026, an estimated $2.39M.
  • Tenax Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2922 holding.
  • Northern Trust first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 28 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.